In particular, ACE-2 polymorphism could be linked to multi-organ failures in COVID-19 patients [80] and may cause mild to severe forms of the disease in certain groups [81], influencing the respective  prevalence and mortality rate [82]. Here, ACE is linked to COVID-19.